Selected research
Industry Research
Sterile Biologics Filling Services Industry Research Report 2026
Market perspective
The global Sterile Biologics Filling Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Sterile Biologics Filling Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Sterile Biologics Filling Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Sterile Biologics Filling Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Sterile Biologics Filling Services include Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier and Bushu Pharmaceuticals, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Sterile Biologics Filling Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Sterile Biologics Filling Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sterile Biologics Filling Services Market by Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Sterile Biologics Filling Services Segment by Type
0.2-1ml
1-5ml
>5ml
Sterile Biologics Filling Services Segment by Application
Vaccines
Biologics and Biosimilar
Others
Sterile Biologics Filling Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile Biologics Filling Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sterile Biologics Filling Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile Biologics Filling Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Sterile Biologics Filling Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.2-1ml
- 1-5ml
- >5ml
Applications
- Vaccines
- Biologics and Biosimilar
- Others
Companies covered
- Baxter BioPharma Solutions
- Boehringer Ingelheim
- Vetter Pharma
- Fresenius Kabi
- Pfizer CentreOne
- Aenova
- WuXi Biologics
- Jubilant HollisterStier
- Bushu Pharmaceuticals
- LSNE Contract Manufacturing
- Ajinomoto Bio-Pharma Services
- CMIC CMO
- GRAM (Grand River Aseptic Manufacturing)
- TAIYO Pharma Tech
- HALIX
- Cognate BioServices
- Afton Scientific
- Novasep
- Emergent BioSolutions
- Seikagaku
- Jiangshu YAOHAI Bio-pharmaceutical
- Akron Biotech
- Symbiosis Pharmaceutical Services
- Techdow
- Vigene Biosciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sterile Biologics Filling Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 0.2-1ml
- 2.2.3 1-5ml
- 2.2.4 >5ml
- 2.3 Sterile Biologics Filling Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Vaccines
- 2.3.3 Biologics and Biosimilar
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Sterile Biologics Filling Services Breakdown Data by Type
- 3.1 Global Sterile Biologics Filling Services Historic Market Size by Type (2021-2026)
- 3.2 Global Sterile Biologics Filling Services Forecasted Market Size by Type (2027-2032)
4 Sterile Biologics Filling Services Breakdown Data by Application
- 4.1 Global Sterile Biologics Filling Services Historic Market Size by Application (2021-2026)
- 4.2 Global Sterile Biologics Filling Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Sterile Biologics Filling Services Market Perspective (2021-2032)
- 5.2 Global Sterile Biologics Filling Services Growth Trends by Region
- 5.2.1 Global Sterile Biologics Filling Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Sterile Biologics Filling Services Historic Market Size by Region (2021-2026)
- 5.2.3 Sterile Biologics Filling Services Forecasted Market Size by Region (2027-2032)
- 5.3 Sterile Biologics Filling Services Market Dynamics
- 5.3.1 Sterile Biologics Filling Services Industry Trends
- 5.3.2 Sterile Biologics Filling Services Market Drivers
- 5.3.3 Sterile Biologics Filling Services Market Challenges
- 5.3.4 Sterile Biologics Filling Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Sterile Biologics Filling Services Players by Revenue
- 6.1.1 Global Top Sterile Biologics Filling Services Players by Revenue (2021-2026)
- 6.1.2 Global Sterile Biologics Filling Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Sterile Biologics Filling Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Sterile Biologics Filling Services Head Office and Area Served
- 6.4 Global Sterile Biologics Filling Services Players, Product Type & Application
- 6.5 Global Sterile Biologics Filling Services Manufacturers Established Date
- 6.6 Global Sterile Biologics Filling Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Sterile Biologics Filling Services Market Size (2021-2032)
- 7.2 North America Sterile Biologics Filling Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Sterile Biologics Filling Services Market Size by Country (2021-2026)
- 7.4 North America Sterile Biologics Filling Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Sterile Biologics Filling Services Market Size (2021-2032)
- 8.2 Europe Sterile Biologics Filling Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Sterile Biologics Filling Services Market Size by Country (2021-2026)
- 8.4 Europe Sterile Biologics Filling Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Sterile Biologics Filling Services Market Size (2021-2032)
- 9.2 Asia-Pacific Sterile Biologics Filling Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Sterile Biologics Filling Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Sterile Biologics Filling Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Sterile Biologics Filling Services Market Size (2021-2032)
- 10.2 South America Sterile Biologics Filling Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Sterile Biologics Filling Services Market Size by Country (2021-2026)
- 10.4 South America Sterile Biologics Filling Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Sterile Biologics Filling Services Market Size (2021-2032)
- 11.2 Middle East & Africa Sterile Biologics Filling Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Sterile Biologics Filling Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Sterile Biologics Filling Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Baxter BioPharma Solutions
- 12.1.1 Baxter BioPharma Solutions Company Information
- 12.1.2 Baxter BioPharma Solutions Business Overview
- 12.1.3 Baxter BioPharma Solutions Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.1.4 Baxter BioPharma Solutions Sterile Biologics Filling Services Product Portfolio
- 12.1.5 Baxter BioPharma Solutions Recent Developments
- 12.2 Boehringer Ingelheim
- 12.2.1 Boehringer Ingelheim Company Information
- 12.2.2 Boehringer Ingelheim Business Overview
- 12.2.3 Boehringer Ingelheim Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.2.4 Boehringer Ingelheim Sterile Biologics Filling Services Product Portfolio
- 12.2.5 Boehringer Ingelheim Recent Developments
- 12.3 Vetter Pharma
- 12.3.1 Vetter Pharma Company Information
- 12.3.2 Vetter Pharma Business Overview
- 12.3.3 Vetter Pharma Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.3.4 Vetter Pharma Sterile Biologics Filling Services Product Portfolio
- 12.3.5 Vetter Pharma Recent Developments
- 12.4 Fresenius Kabi
- 12.4.1 Fresenius Kabi Company Information
- 12.4.2 Fresenius Kabi Business Overview
- 12.4.3 Fresenius Kabi Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.4.4 Fresenius Kabi Sterile Biologics Filling Services Product Portfolio
- 12.4.5 Fresenius Kabi Recent Developments
- 12.5 Pfizer CentreOne
- 12.5.1 Pfizer CentreOne Company Information
- 12.5.2 Pfizer CentreOne Business Overview
- 12.5.3 Pfizer CentreOne Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.5.4 Pfizer CentreOne Sterile Biologics Filling Services Product Portfolio
- 12.5.5 Pfizer CentreOne Recent Developments
- 12.6 Aenova
- 12.6.1 Aenova Company Information
- 12.6.2 Aenova Business Overview
- 12.6.3 Aenova Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.6.4 Aenova Sterile Biologics Filling Services Product Portfolio
- 12.6.5 Aenova Recent Developments
- 12.7 WuXi Biologics
- 12.7.1 WuXi Biologics Company Information
- 12.7.2 WuXi Biologics Business Overview
- 12.7.3 WuXi Biologics Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.7.4 WuXi Biologics Sterile Biologics Filling Services Product Portfolio
- 12.7.5 WuXi Biologics Recent Developments
- 12.8 Jubilant HollisterStier
- 12.8.1 Jubilant HollisterStier Company Information
- 12.8.2 Jubilant HollisterStier Business Overview
- 12.8.3 Jubilant HollisterStier Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.8.4 Jubilant HollisterStier Sterile Biologics Filling Services Product Portfolio
- 12.8.5 Jubilant HollisterStier Recent Developments
- 12.9 Bushu Pharmaceuticals
- 12.9.1 Bushu Pharmaceuticals Company Information
- 12.9.2 Bushu Pharmaceuticals Business Overview
- 12.9.3 Bushu Pharmaceuticals Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.9.4 Bushu Pharmaceuticals Sterile Biologics Filling Services Product Portfolio
- 12.9.5 Bushu Pharmaceuticals Recent Developments
- 12.10 LSNE Contract Manufacturing
- 12.10.1 LSNE Contract Manufacturing Company Information
- 12.10.2 LSNE Contract Manufacturing Business Overview
- 12.10.3 LSNE Contract Manufacturing Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.10.4 LSNE Contract Manufacturing Sterile Biologics Filling Services Product Portfolio
- 12.10.5 LSNE Contract Manufacturing Recent Developments
- 12.11 Ajinomoto Bio-Pharma Services
- 12.11.1 Ajinomoto Bio-Pharma Services Company Information
- 12.11.2 Ajinomoto Bio-Pharma Services Business Overview
- 12.11.3 Ajinomoto Bio-Pharma Services Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.11.4 Ajinomoto Bio-Pharma Services Sterile Biologics Filling Services Product Portfolio
- 12.11.5 Ajinomoto Bio-Pharma Services Recent Developments
- 12.12 CMIC CMO
- 12.12.1 CMIC CMO Company Information
- 12.12.2 CMIC CMO Business Overview
- 12.12.3 CMIC CMO Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.12.4 CMIC CMO Sterile Biologics Filling Services Product Portfolio
- 12.12.5 CMIC CMO Recent Developments
- 12.13 GRAM (Grand River Aseptic Manufacturing)
- 12.13.1 GRAM (Grand River Aseptic Manufacturing) Company Information
- 12.13.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
- 12.13.3 GRAM (Grand River Aseptic Manufacturing) Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.13.4 GRAM (Grand River Aseptic Manufacturing) Sterile Biologics Filling Services Product Portfolio
- 12.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Developments
- 12.14 TAIYO Pharma Tech
- 12.14.1 TAIYO Pharma Tech Company Information
- 12.14.2 TAIYO Pharma Tech Business Overview
- 12.14.3 TAIYO Pharma Tech Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.14.4 TAIYO Pharma Tech Sterile Biologics Filling Services Product Portfolio
- 12.14.5 TAIYO Pharma Tech Recent Developments
- 12.15 HALIX
- 12.15.1 HALIX Company Information
- 12.15.2 HALIX Business Overview
- 12.15.3 HALIX Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.15.4 HALIX Sterile Biologics Filling Services Product Portfolio
- 12.15.5 HALIX Recent Developments
- 12.16 Cognate BioServices
- 12.16.1 Cognate BioServices Company Information
- 12.16.2 Cognate BioServices Business Overview
- 12.16.3 Cognate BioServices Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.16.4 Cognate BioServices Sterile Biologics Filling Services Product Portfolio
- 12.16.5 Cognate BioServices Recent Developments
- 12.17 Afton Scientific
- 12.17.1 Afton Scientific Company Information
- 12.17.2 Afton Scientific Business Overview
- 12.17.3 Afton Scientific Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.17.4 Afton Scientific Sterile Biologics Filling Services Product Portfolio
- 12.17.5 Afton Scientific Recent Developments
- 12.18 Novasep
- 12.18.1 Novasep Company Information
- 12.18.2 Novasep Business Overview
- 12.18.3 Novasep Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.18.4 Novasep Sterile Biologics Filling Services Product Portfolio
- 12.18.5 Novasep Recent Developments
- 12.19 Emergent BioSolutions
- 12.19.1 Emergent BioSolutions Company Information
- 12.19.2 Emergent BioSolutions Business Overview
- 12.19.3 Emergent BioSolutions Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.19.4 Emergent BioSolutions Sterile Biologics Filling Services Product Portfolio
- 12.19.5 Emergent BioSolutions Recent Developments
- 12.20 Seikagaku
- 12.20.1 Seikagaku Company Information
- 12.20.2 Seikagaku Business Overview
- 12.20.3 Seikagaku Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.20.4 Seikagaku Sterile Biologics Filling Services Product Portfolio
- 12.20.5 Seikagaku Recent Developments
- 12.21 Jiangshu YAOHAI Bio-pharmaceutical
- 12.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Information
- 12.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
- 12.21.3 Jiangshu YAOHAI Bio-pharmaceutical Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.21.4 Jiangshu YAOHAI Bio-pharmaceutical Sterile Biologics Filling Services Product Portfolio
- 12.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Developments
- 12.22 Akron Biotech
- 12.22.1 Akron Biotech Company Information
- 12.22.2 Akron Biotech Business Overview
- 12.22.3 Akron Biotech Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.22.4 Akron Biotech Sterile Biologics Filling Services Product Portfolio
- 12.22.5 Akron Biotech Recent Developments
- 12.23 Symbiosis Pharmaceutical Services
- 12.23.1 Symbiosis Pharmaceutical Services Company Information
- 12.23.2 Symbiosis Pharmaceutical Services Business Overview
- 12.23.3 Symbiosis Pharmaceutical Services Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.23.4 Symbiosis Pharmaceutical Services Sterile Biologics Filling Services Product Portfolio
- 12.23.5 Symbiosis Pharmaceutical Services Recent Developments
- 12.24 Techdow
- 12.24.1 Techdow Company Information
- 12.24.2 Techdow Business Overview
- 12.24.3 Techdow Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.24.4 Techdow Sterile Biologics Filling Services Product Portfolio
- 12.24.5 Techdow Recent Developments
- 12.25 Vigene Biosciences
- 12.25.1 Vigene Biosciences Company Information
- 12.25.2 Vigene Biosciences Business Overview
- 12.25.3 Vigene Biosciences Revenue in Sterile Biologics Filling Services Business (2021-2026)
- 12.25.4 Vigene Biosciences Sterile Biologics Filling Services Product Portfolio
- 12.25.5 Vigene Biosciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst